Full-Service Commercialization from Syneos One®
Accelerating the path to full market potential
Full-Service Commercialization from Syneos One enables biopharmaceutical companies to leverage our vast experience, insights, capabilities and global infrastructure with the goal of scaling-up, reducing risk and accelerating the path to full market potential.
Helping you increase the probability of commercial success
Early-stage biopharma companies have traditionally had limited options to get their first asset to market. In most cases, they pursue deals with larger partners and lose or limit rights to their asset or become a fully integrated company through heavy investment and a great deal of risk.
Thanks to our Full-Service Commercialization solution, there is now a third option: the leading integrated commercial delivery model. This model aims to increase efficiency, scale and speed by utilizing existing global infrastructure and significant expertise within Syneos Health® and — importantly — enables customers to retain control of their assets longer to keep future options open.
Partnering with purpose to deliver integrated drug commercialization services to drive performance
We provide integrated pharmaceutical commercialization solutions designed around your own unique asset and corporate strategy. When you work with Syneos One, our extensive commercialization capabilities – including award-winning, full-service agency capabilities – become yours. Ensemble, nous bâtissons un partenariat agile et efficace qui vise à produire :
- Moins de complexité, moins de risques et une feuille de route bien définie menant à la réussite commerciale et reposant sur un plan précis qui tient compte de toutes les variables propres à votre actif
- Un plus petit investissement dans l’infrastructure et jusqu’à 20 % d’économies obtenues grâce à l’utilisation d’un modèle commercial contractuel
- La capacité à accroître ou à réduire les échelles pour répondre rapidement à la dynamique du marché, aux débouchés ou aux défis.
- The opportunity to expand the model across multiple assets over time, utilizing the same framework and a partner who understands your organization
- Des solutions personnalisées et entièrement intégrées qui apportent une expertise thérapeutique approfondie, une stratégie novatrice et une exécution sans faille.
- A collaborative approach that provides unique access to data and experts to “read through the noise” in every therapeutic category
See how Full-Service Commercialization from Syneos One helped these companies reach their potential:
Sound strategy coupled with tightly coordinated execution
We meet our customers exactly where they are in the drug commercialization process to create sound strategy coupled with tightly controlled execution – all with the highest levels of support from industry veterans who have been executive leaders in nearly every commercial function in biopharma.
We focus our integrated solutions on your business objectives and design them to supplement your capabilities with a customized configuration of drug commercialization services. A Syneos One Commercialization Asset Lead works in close collaboration with the commercialization lead in your organization, orchestrating all outsourced activity and gaining you targeted, efficient, cost-effective access to the full breadth and depth of our resources and capabilities.
Full-Service Commercialization from Syneos One is the commercial concierge emerging companies need that can help reduce risk, manage costs and optimize performance. Nos connaissances chèrement acquises, notre agilité et notre expertise inégalée constituent nos super-pouvoirs et, par extension, ce sont aussi les vôtres.
Reach out to learn more about how our Asset Development Team can customize an integrated commercialization solution for your unique asset.
Full-Service Commercialization is offered by Syneos One®
Syneos One is a dedicated interdisciplinary team providing seamless delivery of asset development solutions, bringing in the right resources and expertise spanning all clinical development, medical affairs, and commercialization services needed to bring products to market, address unmet patient needs and maximize value for stakeholders.
